Recursion Pharmaceuticals, Inc. (RXRX) shares outstanding

Shares outstanding · fiscal 2025
447.45M

Recursion Pharmaceuticals, Inc. (RXRX) had 447.45M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 63.2% higher than the 274.21M of fiscal 2024. Figures as of 18 Nov 2026, 12:23 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
447.45M
Change on fiscal 2024
+63.2%
Growth, 5 years
+83.0% a year
Highest on record
447.45Mfiscal 2025
Lowest on record
21.57Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Recursion Pharmaceuticals, Inc. shares outstanding, in more detail

The market data feed counts 622.76M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 83.0% a year. Across the 7 fiscal years on record (2019–2025), the highest was 447.45M in fiscal 2025 and the lowest 21.57M in fiscal 2019.

History · 7 fiscal years

Shares outstanding by fiscal year

Recursion Pharmaceuticals, Inc. shares outstanding, year by year

Recursion Pharmaceuticals, Inc. (RXRX) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025447.45M 63.2% up
2024274.21M 31.9% up
2023207.85M 18.4% up
2022175.54M 40.0% up
2021125.35M 475.5% up
202021.78M 1.0% up
201921.57M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on RXRX

Recursion Pharmaceuticals, Inc., figure by figure

Recursion Pharmaceuticals, Inc. (RXRX) overview: price, valuation and scorecard

Recursion Pharmaceuticals, Inc. shares outstanding: questions and answers

How many shares does Recursion Pharmaceuticals, Inc. have?

Recursion Pharmaceuticals, Inc. (RXRX) had 447.45M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 63.2% higher than the 274.21M of fiscal 2024. The market data feed counts 622.76M shares outstanding today.

What is the growth rate of Recursion Pharmaceuticals, Inc.'s diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 83.0% a year.

What are the highest and lowest diluted share count figures on record for Recursion Pharmaceuticals, Inc.?

Across the 7 fiscal years on record (2019–2025), the highest was 447.45M in fiscal 2025 and the lowest 21.57M in fiscal 2019.

How is Recursion Pharmaceuticals, Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Recursion Pharmaceuticals, Inc. it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Recursion Pharmaceuticals, Inc. (RXRX) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/RXRX/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.